Skip to main content
. 2018 May 25;10:4. doi: 10.1186/s41479-018-0049-2

Table 2.

Sensitivity and specificity of endorsed molecular assays for rapid detection of drug-resistant TB

Assay Detection of drug resistance Sensitivity %
(95% confidence interval)
Specificity %
(95% confidence interval)
References
Xpert MTB/RIF RIF 95 (90–97) 98 (97–99) 44*
Xpert Ultra RIF 92.7 (80.1–98.5) 98 (92.8–99.9) 58*
GenoType MTBDRplus RIF Smear positive sample: 88.2 (72.6–96.7) Smear positive sample: 89.5 (75.2–97.1) 77*
Smear negative and culture positive direct sample: 100 (29.2–100) Smear negative and culture positive direct sample: 63.6 (30.8–89.1)
INH Smear positive sample: 91.7 (77.5–98.3) Smear positive sample: 97.2 (85.5–99.9)
Smear negative and culture positive direct sample: 60 (14.7–94.7) Smear negative and culture positive direct sample: 100 (66.4–100)
MDR-TB (RMP&INH) Smear positive sample: 96.4 (81.7–99.9) Smear positive sample: 100 (88.8–100)
Smear negative and culture positive direct sample: 100 (15.8–100) Smear negative and culture positive direct sample: 100 (47.8–100)
GenoType MTBDRsl FLQ 100 (95.8–100) 98.9 (96.1–99.9) 84*
AMK 93.8 (79.2–99.2) 98.5 (95.5–99.7)
KAN 89.2 (79.1–95.6) 98.5 (95.5–99.7)
CPM 86.2 (68.3–96.1) 95.9 (92.2–98.2)

44*: reference standard was phenotypic culture-based DST

58*: results were compared with phenotypic susceptibility testing and Xpert MTB/RIF

77*: results were compared with the conventional liquid culture based reference standard method, BACTEC MGIT 960 culture and DST

84*: results were compared with phenotypic DST